retatrutide safety profile clinical trials A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Eli Lilly infiltrates anti-obesity market
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
























